NCT01284153 Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study
| NCT ID | NCT01284153 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Breast Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2011-01 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2011-01 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study has the purpose to investigate the benefit of treating breast cancer patients in prone position. This treatment is compared to the standard technique in our center (supine position with or without respiratory gating). The investigators want to compare the doses on the organs at risk (heart and lungs) in the different techniques.
Eligibility Criteria
Inclusion Criteria: * indication for radiotherapy of the breast and /or lymph nodes Exclusion Criteria: * none ( planning study)
Contact & Investigator
Caroline Sweldens, Doctor
STUDY DIRECTOR
UZ Leuven
Frequently Asked Questions
Who can join the NCT01284153 clinical trial?
This trial is open to female participants only, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01284153 currently recruiting?
Yes, NCT01284153 is actively recruiting participants. Contact the research team at caroline.sweldens@uzleuven.be for enrollment information.
Where is the NCT01284153 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT01284153 clinical trial?
NCT01284153 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Caroline Sweldens, Doctor at UZ Leuven. The trial plans to enroll 30 participants.